Galaxy Surfactants Ltd

Galaxy Surfact. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Galaxy Surfactants Ltd

₹ 2,072 -2.42%
30 Apr - close price
galaxysurfactants.com BSE: 540935 NSE: GALAXYSURF
About

Galaxy Surfactants Ltd was Incorporated in 1986. It’s a leading manufacturer of Performance Surfactants and Specialty Care products with over 205 product grades. These products are used in consumer-centric Home and Personal care products like hair care, oral care, skin care, cosmetics, soap, shampoo, lotion, detergent, cleaning products, etc. Preferred suppliers to leading MNC’s, Regional and Local FMCG brands.[1]
The company is India’s Largest Manufacturer of Oleo chemical-based Surfactants and Specialty Care Products for Home Care and Personal Care Industries [2]

Key Points

Product Segment
The company offers 215+ products under Performance Surfactant and Specialty Care Products, covering hair care, oral care, home care, skin care, cosmetics, and toiletries. [1] [2]

Website BSE NSE
  • Market Cap ₹ 7,346 Cr.
  • Current Price ₹ 2,072
  • High / Low ₹ 3,370 / 2,021
  • Stock P/E 24.0
  • Book Value ₹ 640
  • Dividend Yield 1.06 %
  • ROCE 17.4 %
  • ROE 14.9 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 23.5%

Cons

  • The company has delivered a poor sales growth of 6.55% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE Allcap BSE 500 BSE Commodities BSE 250 SmallCap Index BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
929 1,053 1,159 1,232 1,085 980 942 983 940 929 974 1,063 1,042
853 908 1,011 1,100 931 845 819 858 828 827 850 935 936
Operating Profit 76 145 148 132 154 135 123 125 112 102 124 128 106
OPM % 8% 14% 13% 11% 14% 14% 13% 13% 12% 11% 13% 12% 10%
2 1 -2 1 4 7 2 3 6 24 5 9 4
Interest 3 3 4 6 6 6 6 5 6 5 4 4 5
Depreciation 18 18 19 20 22 23 24 25 25 26 27 28 28
Profit before tax 58 124 123 107 131 113 96 98 88 94 99 104 77
Tax % 21% 21% 18% 21% 19% 20% 22% 21% 19% 18% 19% 19% 16%
46 98 100 84 106 91 75 77 71 78 80 85 65
EPS in Rs 12.87 27.75 28.31 23.66 29.96 25.53 21.20 21.84 20.13 21.86 22.48 23.89 18.22
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
1,870 1,799 2,158 2,432 2,761 2,595 2,782 3,684 4,462 3,792 4,008
1,681 1,563 1,886 2,144 2,408 2,226 2,334 3,284 3,894 3,330 3,549
Operating Profit 190 236 271 288 353 369 449 401 568 462 459
OPM % 10% 13% 13% 12% 13% 14% 16% 11% 13% 12% 11%
2 6 10 10 5 6 11 13 10 35 42
Interest 34 34 27 31 30 24 13 13 22 22 18
Depreciation 45 45 47 49 51 62 74 71 83 100 108
Profit before tax 112 163 207 219 277 289 372 329 473 375 374
Tax % 40% 37% 29% 28% 31% 20% 19% 20% 19% 20%
67 103 148 158 191 230 302 263 381 301 307
EPS in Rs 19.03 28.97 41.64 44.57 53.87 64.99 85.22 74.12 107.46 85.03 86.45
Dividend Payout % 21% 31% 14% 16% 15% 22% 21% 24% 20% 26%
Compounded Sales Growth
10 Years: %
5 Years: 7%
3 Years: 11%
TTM: 4%
Compounded Profit Growth
10 Years: %
5 Years: 10%
3 Years: 0%
TTM: -3%
Stock Price CAGR
10 Years: %
5 Years: 8%
3 Years: -11%
1 Year: -20%
Return on Equity
10 Years: %
5 Years: 20%
3 Years: 18%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 35 35 35 35 35 35 35 35 35 35 35
Reserves 342 412 539 683 841 1,032 1,266 1,539 1,847 2,144 2,234
451 412 393 348 298 396 289 421 327 187 149
231 250 315 385 389 348 458 602 518 539 692
Total Liabilities 1,060 1,109 1,283 1,452 1,563 1,812 2,049 2,597 2,728 2,906 3,111
459 436 456 447 519 748 712 760 923 973 992
CWIP 7 51 10 25 83 66 124 205 139 158 215
Investments 0 0 0 0 0 6 43 0 0 198 254
594 623 817 980 962 992 1,170 1,630 1,665 1,576 1,650
Total Assets 1,060 1,109 1,283 1,452 1,563 1,812 2,049 2,597 2,728 2,906 3,111

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
41 170 111 145 283 316 365 5 573 518
-26 -59 -43 -54 -166 -149 -166 -82 -141 -341
-17 -110 -57 -90 -119 -144 -165 59 -264 -189
Net Cash Flow -2 0 11 1 -2 23 34 -18 168 -11

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 43 51 59 63 56 62 62 63 50 57
Inventory Days 68 72 79 75 68 72 91 103 78 82
Days Payable 50 59 63 71 59 60 80 75 52 66
Cash Conversion Cycle 61 64 75 67 65 73 72 91 76 73
Working Capital Days 50 56 65 72 63 72 76 92 71 73
ROCE % 23% 26% 25% 28% 24% 25% 19% 24% 17%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
70.93% 70.93% 70.93% 70.93% 70.93% 70.93% 70.92% 70.91% 70.91% 70.91% 70.91% 70.91%
2.01% 2.82% 2.78% 2.89% 2.99% 3.08% 3.61% 3.75% 3.87% 4.08% 4.19% 4.10%
13.62% 12.73% 12.72% 12.66% 12.64% 12.56% 12.43% 12.73% 12.71% 12.99% 12.98% 12.94%
13.44% 13.52% 13.59% 13.52% 13.43% 13.44% 13.03% 12.60% 12.51% 12.00% 11.91% 12.04%
No. of Shareholders 62,89563,03464,78764,03763,85863,39659,61158,02956,32852,09150,87551,956

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls